​

Boston Scientific (BSX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

BSX Stock Forecast

Boston Scientific (BSX) stock forecast, based on 43 Wall Street analysts, predicts a 12-month average price target of $108.35, with a high of $130.00 and a low of $94.00. This represents a 42.04% increase from the last price of $76.28.

$35 $54 $73 $92 $111 $130 High: $130 Avg: $108.35 Low: $94 Last Closed Price: $76.28

BSX Stock Rating

Boston Scientific stock's rating consensus is Buy, based on 43 Wall Street analysts. The breakdown includes 2 Strong Buy (4.65%), 38 Buy (88.37%), 3 Hold (6.98%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 43 0 3 38 2 Strong Sell Sell Hold Buy Strong Buy

BSX Price Target Upside V Benchmarks

TypeNameUpside
StockBoston Scientific42.04%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks20.73%

Price Target Trends

1M3M12M
# Anlaysts162238
Avg Price Target$107.75$110.41$117.11
Last Closing Price$76.28$76.28$76.28
Upside/Downside41.26%44.74%53.53%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 267261--34
Jan, 267252--34
Dec, 257252--34
Nov, 257252--34
Oct, 257252--34
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 17, 2026William PlovanicCanaccord Genuity$109.00$74.7345.86%42.89%
Feb 06, 2026Lee HambrightBernstein$112.00$77.4644.59%46.83%
Feb 05, 2026Truist Financial$95.00$77.0223.34%24.54%
Feb 05, 2026RBC Capital$115.00$77.1749.02%50.76%
Feb 05, 2026Needham$97.00$75.5228.44%27.16%
Feb 05, 2026Mizuho Securities$115.00$75.2952.74%50.76%
Feb 05, 2026Evercore ISI$96.00$75.6526.90%25.85%
Feb 05, 2026Wells Fargo$94.00$75.5024.50%23.23%
Feb 05, 2026Goldman Sachs$99.00$75.5031.13%29.79%
Feb 05, 2026Robert W. Baird$101.00$75.5033.77%32.41%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 06, 2026BernsteinOutperformOutperformhold
Feb 05, 2026RBC CapitalOutperformOutperformhold
Feb 05, 2026CitigroupBuyBuyhold
Feb 04, 2026BTIGBuyBuyhold
Feb 02, 2026Cowen & Co.BuyBuyhold
Jan 15, 2026NeedhamBuyBuyhold
Jan 14, 2026CitigroupBuyBuyhold
Jan 09, 2026Goldman SachsBuyBuyhold
Dec 17, 2025UBSBuyBuyhold
Dec 17, 2025RBC CapitalOutperformOutperformhold

Financial Forecast

EPS Forecast

$0 $1 $2 $3 $4 $5 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$0.69$0.45$1.08$1.26$1.96---
Avg Forecast$1.61$1.73$2.01$2.47$2.81$3.20$3.56$3.96
High Forecast$1.65$1.78$2.02$2.48$2.86$3.93$4.46$4.08
Low Forecast$1.59$1.68$2.00$2.46$2.76$2.46$2.61$3.80
Surprise %-57.14%-73.99%-46.27%-48.99%-30.25%---

Revenue Forecast

$10B $14B $18B $22B $26B $30B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$11.89B$12.68B$14.24B$16.75B$20.07B---
Avg Forecast$11.87B$12.68B$14.12B$16.61B$18.79B$20.70B$22.61B$24.63B
High Forecast$12.08B$12.97B$14.13B$16.68B$19.18B$20.70B$22.67B$25.22B
Low Forecast$11.73B$12.36B$14.08B$16.54B$18.30B$20.70B$22.54B$23.83B
Surprise %0.12%-0.02%0.88%0.83%6.83%---

Net Income Forecast

$500M $2B $3B $4B $6B $7B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.04B$698.00M$1.59B$1.85B$2.89B---
Avg Forecast$947.28M$909.12M$1.57B$3.61B$4.11B$4.68B$3.93B$5.80B
High Forecast$1.14B$1.09B$1.88B$3.62B$4.19B$5.76B$6.52B$5.98B
Low Forecast$757.83M$727.30M$1.26B$3.59B$4.04B$3.60B$3.81B$5.55B
Surprise %9.79%-23.22%1.46%-48.62%-29.84%---

BSX Forecast FAQ

Is Boston Scientific stock a buy?

Boston Scientific stock has a consensus rating of Buy, based on 43 Wall Street analysts. The rating breakdown includes 2 Strong Buy, 38 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Boston Scientific is a favorable investment for most analysts.

What is Boston Scientific's price target?

Boston Scientific's price target, set by 43 Wall Street analysts, averages $108.35 over the next 12 months. The price target range spans from $94 at the low end to $130 at the high end, suggesting a potential 42.04% change from the previous closing price of $76.28.

How does Boston Scientific stock forecast compare to its benchmarks?

Boston Scientific's stock forecast shows a 42.04% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (20.73%).

What is the breakdown of analyst ratings for Boston Scientific over the past three months?

  • February 2026: 20.59% Strong Buy, 76.47% Buy, 2.94% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 20.59% Strong Buy, 73.53% Buy, 5.88% Hold, 0% Sell, 0% Strong Sell.
  • December 2025: 20.59% Strong Buy, 73.53% Buy, 5.88% Hold, 0% Sell, 0% Strong Sell.

What is Boston Scientific’s EPS forecast?

Boston Scientific's average annual EPS forecast for its fiscal year ending in December 2026 is $3.2, marking a 63.27% increase from the reported $1.96 in 2025. Estimates for the following years are $3.56 in 2027, and $3.96 in 2028.

What is Boston Scientific’s revenue forecast?

Boston Scientific's average annual revenue forecast for its fiscal year ending in December 2026 is $20.7B, reflecting a 3.10% increase from the reported $20.07B in 2025. The forecast for 2027 is $22.61B, and $24.63B for 2028.

What is Boston Scientific’s net income forecast?

Boston Scientific's net income forecast for the fiscal year ending in December 2026 stands at $4.68B, representing an 62.16% increase from the reported $2.89B in 2025. Projections indicate $3.93B in 2027, and $5.8B in 2028.